CRON

Cronos Group Inc. (CRON) | Rumor.io

Cronos Group

CRON

Attention (50-day avg)0%

Attention rank (50-day avg)#1,448

Bullish sentiment (50-day avg)83%

Price to earnings ratio17.9

Market capitalization1.3B

Earnings per share0.19

Dividend yield (TTM)—

Revenue (annual)146.6M

Net income (annual)-2.9M

Social

What share of all stock conversation is about CRON?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% +0	0% +0	0% 0	0.01% -0.01

Aug 6

Cronos Group reported record net revenue, gross profit, and Adjusted EBITDA in Q2 2026, with a 51% year-over-year increase in organic, constant-currency net revenue.
The company achieved record net revenue in Canada, Israel, and other regions, led by strong demand for its PEACE NATURALS brand in Germany.
Cronos Group repurchased 12.3 million shares and maintained a cash hoard, which helped the company remain profitable despite FX swings and market volatility.

Generated by AI

Sentiment

Of the messages about CRON that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	100% +14.29	97.73% +71.41	61.44% -32.56	84.53% -2.01
Bearish	0% -14.29	2.27% -71.41	38.56% +32.56	15.47% +2.01

Bullish· Aug 6

Cronos Group Inc. has shown impressive organic growth, with a 25% YoY increase in Canada, surpassing the sector's stagnant 1% growth.
The company's capital discipline provides a high floor in value, with a focus on higher-margin products like vapes and gummies, creating economic moats in the market.
Cronos' undervalued equity position suggests that the stock should be at a higher price, potentially reaching $10.00 if it were an IPO, given its strong fundamentals and growing revenue.

Bearish· Apr 23

The market is expected to react negatively to cannabis news, with the asset's share price potentially dropping despite positive developments.
The elimination of 280E tax burden may not be enough to significantly boost the asset's price, as the market has already reacted poorly to the news.
The asset's price may be influenced by the performance of other cannabis stocks, with the current lack of movement suggesting a potential disconnect between the asset and the broader market.

Generated by AI

Topics

Of the messages about CRON that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Announcements	0%	94.44%	61.11%	74.6%
Technical Analysis	0%	0%	27.78%	4.29%
Earnings	0%	0%	0%	5.53%
Analysts	100%	5.56%	2.78%	0.47%
Macro	0%	0%	8.33%	3.33%
Controversies	0%	0%	0%	11.78%

Earnings· Feb 26

Cronos Group reported a net loss of $58.4M in Q4 2020, missing estimates.
The company's Q4 2020 loss per share was $0.31, beating Earnings Whisper but missing consensus estimates.
Cronos Group's Q4 2020 revenue was $17.05M, beating estimates and up from $7.31M in the same period last year.

Analysts· May 11

CIBC cuts target price for Cronos Group to $8 from $8.50.
Raymond James and Stifel Nicolaus reiterate or lower price targets for Cronos Group to $6.50 or $7.50.
Canaccord Genuity maintains a sell rating and $6.50 price target for Cronos Group.

Announcements· Mar 6

Cronos Group Inc. is developing a new app, which may impact existing projects like VVS, Moonlander, Obsidian, and Wolfswap.
The new app is expected to consolidate revenue streams, potentially affecting current projects.
Cronos Network token (CRO) may see increased demand as a result of the new app's launch.

Controversies· Aug 31

Cronos Group Inc. (CRON) is facing investigations by multiple law firms over potential securities violations and allegations of fraud.
The company's CEO is a former counsel for Diego, a possible indication of a partnership or conflict of interest.
The swift response by Cronos to fire a lawsuit back at Citron Research may indicate that the company is confident in its position and prepared for potential legal action.

Macro· Mar 31

Cronos Group Inc. has been impacted by the crypto market crash, with its token experiencing a significant decline in value.
The company's token is closely tied to the broader crypto market, with its price highly correlated with the overall market performance.
The crypto market's recent downturn has led to a decrease in investor sentiment and a reduction in trading activity, affecting Cronos Group Inc. and other crypto-related assets.

Technical Analysis· Nov 6

$CRON has broken an RSI orange level, with a target of $8.06 if it breaks another RSI wall.
The stock has a possible inverse head and shoulders breakout, and all moving averages are opening upward.
$CRON's Aroon indicator has reached an uptrend, and the Relative Strength Index is crossing 70, raising questions about overbought conditions.

Generated by AI

Community

Of the messages about CRON, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	100%	90%	78.42%	87.29%
Newcomers	0%	10%	21.58%	12.71%

Regulars· Aug 6

Cronos Group's Q2 earnings results showed a significant increase in net revenue, from $33.5 million to $53.0 million, with the company now in the black due to its cash hoard.
Regular participants are focusing on Cronos Group's undervalued equity, with some suggesting it should be valued at $10.00, and others pointing out its cash reserves and FX swings as major factors.
The company's Q2 results and earnings details were released on August 6, with the full 8-K attached, showing a substantial increase in net revenue and a strong momentum compared to other cannabis companies.

Newcomers· Dec 12

Newcomers are drawn to Cronos Group Inc. due to its simple thesis as a top 10 cannabis player in Canada, with a net-net valuation at $2.2 per share.
Fresh investors are focusing on Cronos' large cash balance and potential for rapid revenue growth, which could lead to increased valuation multiples.
The recent 15-17% after-hours stock price surge is catching the attention of new followers, with some speculating that the company's stock will continue to rise in response to potential policy changes.

Generated by AI

Investing.com -- Cronos Group’s manufacturing capacity, cannabis genetics and branded product portfolio are drawing renewed attention after the company showcased its operations at an investor day, prompting an analyst to raise its 12-month price target to C$5.50 from C$5.25.

1d agoYahoo Finance

Cronos Group Inc. stock falls Thursday, underperforms market

5d agoMarketWatch

Cronos Group Investor Day Highlights Cannabis Growth, Cash Flow and Global Ambitions

Cronos Group (NASDAQ:CRON) used its first Investor Day to outline its cultivation, genetics, brand and financial strategy, emphasizing its purpose-built greenhouse partnership with Mucci Farms, continued international expansion and a focus on cash flow generation. Chief Executive Officer Mike Goren

5d agoYahoo Finance

Cronos Group Inc. (CRON:CA) Analyst/Investor Day - Slideshow (TSX:CRON:CA) 2026-09-24

5d agoSeeking Alpha

Labaton Keller Sucharow LLP Announces a Proposed Settlement in the Cronos U.S. Securities Settlement

6d agoca.finance.yahoo.com

Cronos Group Inc. stock rises Tuesday, outperforms market

7d agoMarketWatch

Also Discussed

Investors talking about CRON also mention

#	Name	Attention
1	Canopy Growth CorporationCGC	0%-0.01
2	Aurora Cannabis Inc.ACB	0%-0.01
3	Tilray Brands Inc.TLRY	0.02%0
4	Village Farms International Inc.VFF	0.01%-0.01
5	Amplify Alternative Harvest ETFMJ	0%new
6	IGC Pharma Inc.IGC	0.01%+0
7	HEXO - HEXO Corp.	——
8	Constellation Brands Inc. Class ASTZ	0%-0.01
9	Altria Group, Inc.MO	0.06%+0.06
10	Organigram Global Inc.OGI	0.01%new

Cronos Group Inc.

Healthcare
Drug Manufacturers - Specialty & Generic

Cronos Group Inc. is a cannabinoid company focused on the cultivation, production, distribution, and marketing of cannabis products. The company serves adult-use and medical cannabis markets in Canada and Israel, while also reaching international customers through a portfolio of branded products. Its offerings include dried flowers, pre-rolls, oils, vaporizers, edibles, tinctures, and hemp-derived wellness products. Key brands include Spinach, Peace Naturals, Lord Jones, and LIT, which position the company across both recreational and wellness-oriented categories. Cronos Group also emphasizes product development, research, and innovation in cannabinoid-based formulations, supporting its role in a competitive consumer and healthcare-related market.

Website

Location

4491 Concession Road 12

Stayner, ON, L0M 1S0

Canada

Social

What share of all stock conversation is about CRON?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% +0	0% +0	0% 0	0.01% -0.01

Aug 6

Cronos Group reported record net revenue, gross profit, and Adjusted EBITDA in Q2 2026, with a 51% year-over-year increase in organic, constant-currency net revenue.
The company achieved record net revenue in Canada, Israel, and other regions, led by strong demand for its PEACE NATURALS brand in Germany.
Cronos Group repurchased 12.3 million shares and maintained a cash hoard, which helped the company remain profitable despite FX swings and market volatility.

Generated by AI

Sentiment

Of the messages about CRON that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	100% +14.29	97.73% +71.41	61.44% -32.56	84.53% -2.01
Bearish	0% -14.29	2.27% -71.41	38.56% +32.56	15.47% +2.01

Bullish· Aug 6

Cronos Group Inc. has shown impressive organic growth, with a 25% YoY increase in Canada, surpassing the sector's stagnant 1% growth.
The company's capital discipline provides a high floor in value, with a focus on higher-margin products like vapes and gummies, creating economic moats in the market.
Cronos' undervalued equity position suggests that the stock should be at a higher price, potentially reaching $10.00 if it were an IPO, given its strong fundamentals and growing revenue.

Bearish· Apr 23

The market is expected to react negatively to cannabis news, with the asset's share price potentially dropping despite positive developments.
The elimination of 280E tax burden may not be enough to significantly boost the asset's price, as the market has already reacted poorly to the news.
The asset's price may be influenced by the performance of other cannabis stocks, with the current lack of movement suggesting a potential disconnect between the asset and the broader market.

Generated by AI

Topics

Of the messages about CRON that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Announcements	0%	94.44%	61.11%	74.6%
Technical Analysis	0%	0%	27.78%	4.29%
Earnings	0%	0%	0%	5.53%
Analysts	100%	5.56%	2.78%	0.47%
Macro	0%	0%	8.33%	3.33%
Controversies	0%	0%	0%	11.78%

Earnings· Feb 26

Cronos Group reported a net loss of $58.4M in Q4 2020, missing estimates.
The company's Q4 2020 loss per share was $0.31, beating Earnings Whisper but missing consensus estimates.
Cronos Group's Q4 2020 revenue was $17.05M, beating estimates and up from $7.31M in the same period last year.

Analysts· May 11

CIBC cuts target price for Cronos Group to $8 from $8.50.
Raymond James and Stifel Nicolaus reiterate or lower price targets for Cronos Group to $6.50 or $7.50.
Canaccord Genuity maintains a sell rating and $6.50 price target for Cronos Group.

Announcements· Mar 6

Cronos Group Inc. is developing a new app, which may impact existing projects like VVS, Moonlander, Obsidian, and Wolfswap.
The new app is expected to consolidate revenue streams, potentially affecting current projects.
Cronos Network token (CRO) may see increased demand as a result of the new app's launch.

Controversies· Aug 31

Cronos Group Inc. (CRON) is facing investigations by multiple law firms over potential securities violations and allegations of fraud.
The company's CEO is a former counsel for Diego, a possible indication of a partnership or conflict of interest.
The swift response by Cronos to fire a lawsuit back at Citron Research may indicate that the company is confident in its position and prepared for potential legal action.

Macro· Mar 31

Cronos Group Inc. has been impacted by the crypto market crash, with its token experiencing a significant decline in value.
The company's token is closely tied to the broader crypto market, with its price highly correlated with the overall market performance.
The crypto market's recent downturn has led to a decrease in investor sentiment and a reduction in trading activity, affecting Cronos Group Inc. and other crypto-related assets.

Technical Analysis· Nov 6

$CRON has broken an RSI orange level, with a target of $8.06 if it breaks another RSI wall.
The stock has a possible inverse head and shoulders breakout, and all moving averages are opening upward.
$CRON's Aroon indicator has reached an uptrend, and the Relative Strength Index is crossing 70, raising questions about overbought conditions.

Generated by AI

Community

Of the messages about CRON, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	100%	90%	78.42%	87.29%
Newcomers	0%	10%	21.58%	12.71%

Regulars· Aug 6

Cronos Group's Q2 earnings results showed a significant increase in net revenue, from $33.5 million to $53.0 million, with the company now in the black due to its cash hoard.
Regular participants are focusing on Cronos Group's undervalued equity, with some suggesting it should be valued at $10.00, and others pointing out its cash reserves and FX swings as major factors.
The company's Q2 results and earnings details were released on August 6, with the full 8-K attached, showing a substantial increase in net revenue and a strong momentum compared to other cannabis companies.

Newcomers· Dec 12

Newcomers are drawn to Cronos Group Inc. due to its simple thesis as a top 10 cannabis player in Canada, with a net-net valuation at $2.2 per share.
Fresh investors are focusing on Cronos' large cash balance and potential for rapid revenue growth, which could lead to increased valuation multiples.
The recent 15-17% after-hours stock price surge is catching the attention of new followers, with some speculating that the company's stock will continue to rise in response to potential policy changes.

Generated by AI

Cronos Group

Social

Aug 6

Bullish· Aug 6

Bearish· Apr 23

Earnings· Feb 26

Analysts· May 11

Announcements· Mar 6

Controversies· Aug 31

Macro· Mar 31

Technical Analysis· Nov 6

Regulars· Aug 6

Newcomers· Dec 12

Can Cronos turn production and brand power into a bigger cannabis comeback?

Cronos Group Inc. stock falls Thursday, underperforms market

Cronos Group Investor Day Highlights Cannabis Growth, Cash Flow and Global Ambitions

Cronos Group Inc. (CRON:CA) Analyst/Investor Day - Slideshow (TSX:CRON:CA) 2026-09-24

Labaton Keller Sucharow LLP Announces a Proposed Settlement in the Cronos U.S. Securities Settlement

Cronos Group Inc. stock rises Tuesday, outperforms market

Also Discussed

Cronos Group Inc.

Company Information

Location

Can Cronos turn production and brand power into a bigger cannabis comeback?

Cronos Group Inc. stock falls Thursday, underperforms market

Cronos Group Investor Day Highlights Cannabis Growth, Cash Flow and Global Ambitions

Cronos Group Inc. (CRON:CA) Analyst/Investor Day - Slideshow (TSX:CRON:CA) 2026-09-24

Labaton Keller Sucharow LLP Announces a Proposed Settlement in the Cronos U.S. Securities Settlement

Cronos Group Inc. stock rises Tuesday, outperforms market

Also Discussed

Social

Aug 6

Bullish· Aug 6

Bearish· Apr 23

Earnings· Feb 26

Analysts· May 11

Announcements· Mar 6

Controversies· Aug 31

Macro· Mar 31

Technical Analysis· Nov 6

Regulars· Aug 6

Newcomers· Dec 12